Effectiveness of DMF (Dimethyl Fumarate) and Its Impact on PROs (Patient Reported Outcomes) in Treatment-Naive or Suboptimal IFN (Interferon) or GA (Glatiramer Acetate) Responders With RRMS (ImPROve)

Name: Effectiveness of DMF (Dimethyl Fumarate) and Its Impact on PROs (Patient Reported Outcomes) in Treatment-Naive or Suboptimal IFN (Interferon) or GA (Glatiramer Acetate) Responders With RRMS (ImPROve)
Published: 2015
License: Public Domain

Biogen · 2015

ClinicalTrials.gov · Datasets · License: Public Domain · 2015

Open Source ↗

multiple-sclerosis

multiple sclerosis, relapsing-remitting, relapsing-remitting multiple sclerosis, observational

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Effectiveness of DMF (Dimethyl Fumarate) and Its Impact on PROs (Patient Reported Outcomes) in Treatment-Naive or Suboptimal IFN (Interferon) or GA (Glatiramer Acetate) Responders With RRMS (ImPROve)

Related documents